Skip to content
Intravacc
IntravaccIntravacc
  • Publications
    • Scientific Publications
    • Vaccsheets
    • Annual report
  • Events
  • News
  • Career
  • Partnering
  • About us
    • Company profile
    • Board of Directors
    • Management Team
    • Supervisory Board
    • Scientific advisory board
  • Services
    • Vaccine development
      • Process development
        • Upstream processing
        • Downstream processing
        • Formulation
      • Vaccine strain design
      • GMP
    • Assays
      • Analytical method development
  • Platforms
    • Cell based platform
    • OMV Platform
    • Conjugate vaccines
  • Products
  • 3R Research
Contact
Search:
  • Publications
    • Scientific Publications
    • Vaccsheets
    • Annual report
  • Events
  • News
  • Career
  • Partnering
  • About us
    • Company profile
    • Board of Directors
    • Management Team
    • Supervisory Board
    • Scientific advisory board
  • Services
    • Vaccine development
      • Process development
        • Upstream processing
        • Downstream processing
        • Formulation
      • Vaccine strain design
      • GMP
    • Assays
      • Analytical method development
  • Platforms
    • Cell based platform
    • OMV Platform
    • Conjugate vaccines
  • Products
  • 3R Research

Platforms Cell based

You are here:
  1. Home
  2. Category "Platforms Cell based"

Development of an animal component free production process for Sabin inactivated polio vaccine

Platforms Cell based, Vaccine development servicesBy Mirjam Hartman20/10/2022

First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial

GMP Manufacturing, Platforms Cell basedBy Mirjam Hartman24/11/2021

Novel mumps virus epitopes reveal robust cytotoxic T cell responses after natural infection

Platforms Cell basedBy Mirjam Hartman04/08/2021

Genetic Analysis Reveals Differences in CD8+ T Cell Epitope Regions That May Impact Cross-Reactivity of Vaccine-Induced T Cells against Wild-Type Mumps Viruses

Platforms Cell basedBy Mirjam Hartman04/08/2021

Kinetic model for adherent Vero cell growth and poliovirus production in batch bioreactors

Platforms Cell basedBy Mirjam Hartman02/08/2021

Comparison of initial feasibility of host cell lines for viral vaccine production

Platforms Cell basedBy Mirjam Hartman09/10/2020

Isoelectric point determination of live polioviruses by capillary isoelectric focusing with whole column imaging detection

Platforms Cell basedBy Mirjam Hartman09/10/2020

Mixed-bed ion exchange chromatography employing a salt-free pH gradient for improved sensitivity and compatibility in MudPIT

Platforms Cell basedBy Mirjam Hartman09/10/2020

Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals

Platforms Cell basedBy Mirjam Hartman09/10/2020

Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods

Platforms Cell basedBy Mirjam Hartman09/10/2020
→12→

Copyright © 2018 Intravacc - Privacy & Disclaimer

ISO Certifications: ISO 14001

Go to Top

We gebruiken cookies om u de beste ervaring op onze website te bieden. U kunt meer te weten komen over welke cookies we gebruiken of ze uitschakelen in instellingen .

Intravacc
Privacy overzicht

Deze website maakt gebruik van cookies zodat we u de best mogelijke gebruikerservaring kunnen bieden. Cookie-informatie wordt opgeslagen in uw browser en voert functies uit zoals u herkennen wanneer u terugkeert naar onze website en ons team helpen begrijpen welke delen van de website u het meest interessant en nuttig vindt.

Strikt noodzakelijke cookies

Strikt noodzakelijke cookies moeten te allen tijde zijn ingeschakeld, zodat we uw voorkeuren voor cookie-instellingen kunnen opslaan.

Als u deze cookie uitschakelt, kunnen we uw voorkeuren niet opslaan. Dit betekent dat u elke keer dat u deze website bezoekt, cookies opnieuw moet in- of uitschakelen.